wow, that's a really long post that mentions the "big picture" at the end - and you still don't grasp the true big picture. everyone knows we have an effective drug - we hit our primary endpoint in HIV 2 years ago.

and yet we sit with a 90% loss in value over the past year, no approved drug because we hired an incompetent CRO who totally botched the BLA submission. And we also spent most of our time, money and resources chasing COVID (which may amount to zero), instead of focusing and nailing down our approval in HIV.

So the big picture is that we have a great drug, and a management team that has mis-managed the process of getting it to market and getting an approval.

Thankfully you're not the CEO.